Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00237861
NCT00237861
Completed
Phase 4

Effectiveness of Atypical Vs Conventional Antipsychotics

Yale University0 sitesOctober 12, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSchizophrenia
Drugsrisperidoneolanzapinequetiapine

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
Yale University
Primary Endpoint
PANSS
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

This study will compare the effectiveness of newer atypical antipsychotics versus older conventional antipsychotics in treating schizophrenia.

Detailed Description

At seven participating hospitals, acutely exacerbated patients with schizophrenia were randomly assigned to treatment with antipsychotic from the atypical class vs antipsychotic from the conventional class. Medication choice within class, dose, concomitant medications, and other prescribing decisions were left to the community prescriber. Patients were followed for one year after discharge.

Registry
clinicaltrials.gov
Start Date
October 12, 2005
End Date
December 2002
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •hospitalized for schizophrenia

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

PANSS

Retention.

Secondary Outcomes

  • EPS, TD.

Similar Trials

Completed
Phase 4
Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in SchizophreniaSchizophrenia
NCT01164059University of Bremen149
Completed
Phase 4
Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia NervosaEating Disorders
NCT00685334New York State Psychiatric Institute22
Completed
Not Applicable
A Comparative Study of New Medications for Psychosis in AdolescentsPsychotic DisordersSchizophreniaSchizophreniform DisordersSchizoaffective Disorders
NCT00222495University of Minnesota30
Unknown
Not Applicable
Antipsychotic to Treat Psychosis SyndromePsychotic Disorders
NCT02137616Central South University300
Terminated
Phase 4
A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy ControlsSchizophrenia
NCT00934635Janssen-Cilag G.m.b.H2